Biogen in promising but risky limelight after Eli Lilly’s Alzheimer’s drug fails
November 25, 2016 at 11:33 AM EST
Biogen is using the same scientific approach to treating the disease as Eli Lilly.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.